1. Fernández-Ortega P, Caloto MT, Chirveches E, Marquilles R, Francisco JS, Quesada A, et al. Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients’ quality of life. Support Care Cancer 2012;20:3141–3148.
3. Griffin AM, Butow PN, Coates AS, Childs AM, Ellis PM, Dunn SM, et al. On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 1996;7:189–195.
4. Hoang HTX, Molassiotis A, Chan CW, Nguyen TH, Liep Nguyen V. New-onset insomnia among cancer patients undergoing chemotherapy: prevalence, risk factors, and its correlation with other symptoms. Sleep Breath 2020;24:241–251.
5. Ho SY, Rohan KJ, Parent J, Tager FA, McKinley PS. A longitudinal study of depression, fatigue, and sleep disturbances as a symptom cluster in women with breast cancer. J Pain Symptom Manage 2015;49:707–715.
7. Schneider A, Kotronoulas G, Papadopoulou C, McCann L, Miller M, McBride J, et al. Trajectories and predictors of state and trait anxiety in patients receiving chemotherapy for breast and colorectal cancer: results from a longitudinal study. Eur J Oncol Nurs 2016;24:1–7.
8. Jacobsen PB, Bovbjerg DH, Redd WH. Anticipatory anxiety in women receiving chemotherapy for breast cancer. Health Psychol 1993;12:469–475.
9. Watson M, Meyer L, Thomson A, Osofsky S. Psychological factors predicting nausea and vomiting in breast cancer patients on chemotherapy. Eur J Cancer 1998;34:831–837.
10. Molassiotis A, Yam BM, Yung H, Chan FY, Mok TS. Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients. Support Care Cancer 2002;10:139–145.
11. Grassi L, Berardi MA, Ruffilli F, Meggiolaro E, Andritsch E, Sirgo A, et al. Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study. Psychother Psychosom 2015;84:339–347.
12. Whitford HS, Olver IN. When expectations predict experience: the influence of psychological factors on chemotherapy toxicities. J Pain Symptom Manage 2012;43:1036–1050.
13. Lockefeer JP, De Vries J. What is the relationship between trait anxiety and depressive symptoms, fatigue, and low sleep quality following breast cancer surgery? Psychooncology 2013;22:1127–1133.
15. Molassiotis A, Stamataki Z, Kontopantelis E. Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting. Support Care Cancer 2013;21:2759–2767.
16. Yun YH, Mendoza TR, Kang IO, You CH, Roh JW, Lee CG, et al. Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manage 2006;31:345–352.
18. Kautio AL, Haanpää M, Saarto T, Kalso E. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manage 2008;35:31–39.
19. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–370.
20. Oh SM, Min KJ, Park DB. A comparison of normal, depressed and anxious groups: a study on the standardization of the hospital anxiety and depressed scale for Koreans. J Korean Neuropsychiatr Assoc 1999;38:289–296.
21. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res 2002;52:69–77.
22. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD. The temperament and character inventory (TCI): a guide to its development and use. St-Louis, MO: Washington University; 1994.
23. Goth K, Cloninger CR, Schmeck K. Das Temperament und Charakter Inventar Kurzversion für Erwachsene - TCI R Kurz. Frankfurt: JW Goethe University; 2003.
24. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50:975–990.
25. Heath AC, Cloninger CR, Martin NG. Testing a model for the genetic structure of personality: a comparison of the personality systems of Cloninger and Eysenck. J Pers Soc Psychol 1994;66:762–775.
26. Marchesi C, De Panfilis C, Cantoni A, Giannelli MR, Maggini C. Effect of pharmacological treatment on temperament and character in panic disorder. Psychiatry Res 2008;158:147–154.
27. Boz C, Gazioglu S, Altunayoglu V, Hocaoglu C. Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache. Psychiatry Clin Neurosci 2007;61:534–542.
28. Hirano S, Sato T, Narita T, Kusunoki K, Ozaki N, Kimura S, et al. Evaluating the state dependency of the temperament and character inventory dimensions in patients with major depression: a methodological contribution. J Affect Disord 2002;69:31–38.
29. Peirson AR, Heuchert JW. The relationship between personality and mood: comparison of the BDI and the TCI. Pers Individ Differ 2001;30:391–399.
30. Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. New York: Guilford Press; 2013.
31. Aiken LS, West SG. Multiple regression: testing and interpreting interactions. Thousand Oaks: Sage; 1991.
33. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev 1986;4:167–226.
34. Clarke P, Macleod C, Shirazee N. Prepared for the worst: readiness to acquire threat bias and susceptibility to elevate trait anxiety. Emotion 2008;8:47–57.
35. Wirtz PW, Rohrbeck CA, Burns KM. Anxiety effects on disaster precautionary behaviors: a multi-path cognitive model. J Health Psychol 2019;24:1401–1411.
36. Van Der Pligt J. Perceived risk and vulnerability as predictors of precautionary behaviour. Br J Health Psychol 1998;3:1–14.
37. Schwarzer R. Optimism, vulnerability, and self-beliefs as health-related cognitions: a systematic overview. Psychol Health 1994;9:161–180.
39. Min BB, Oh HS, Lee JY. Temperament and character inventory-family manual. Seoul: Maumsarang; 2007.
40. Ream E, Richardson A. The role of information in patients’ adaptation to chemotherapy and radiotherapy: a review of the literature. Eur J Cancer Care (Engl) 1996;5:132–138.